Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Canagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms CARAT
- 01 Mar 2019 Status changed from recruiting to discontinued due to difficulty with reaching enrollment goals and study timeline.
- 03 Feb 2017 Planned End Date changed from 1 Apr 2018 to 31 Jul 2018.
- 03 Feb 2017 Planned primary completion date changed from 1 Apr 2018 to 31 Jul 2018.